Form 4 for DMAC DiaMedica Therapeutics Inc.
Accepted 2025-04-08 00:00:00 ET · period of report 2025-04-07 · accession 0001760016-25-000004 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| D | 2025-04-08 | 2025-04-07 | DMAC | Pilnik Richard D. | Dir | M - OptEx | $2.11 | +24.0K | 313.0K | +8% | +$50.6K |
| D | 2025-04-08 | 2025-04-07 | DMAC | Pilnik Richard D. | Dir | M - OptEx | $0.00 | -24.0K | 0 | -100% | $0 |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Voting Common Shares, no par value per share | 2025-04-07 | M | A | 24,000 | $2.11 | 312,995 | D | — | — | (F1) Represents an exercise price of $3.00 Canadian dollars, converted to U.S. dollars at an exchange rate of CAD$0.7032 to U.S. $1.00 on April 4, 2025. (F2) Includes 7,588 voting common shares issuable upon settlement of deferred share units granted under the DiaMedica Therapeutics Inc. Deferred Share Unit Plan and 139,954 shares issuable upon settlement of deferred stock units granted under the DiaMedica Therapeutics Inc. 2019 Omnibus Incentive Plan, as amended from time to time. |
| 2 | Derivative | Stock Option (right to buy) | 2025-04-07 | M | D | 24,000 | $0.00 | 0 | D | $2.11 · — to 2025-12-01 | 24,000 Voting Common Shares | (F1) Represents an exercise price of $3.00 Canadian dollars, converted to U.S. dollars at an exchange rate of CAD$0.7032 to U.S. $1.00 on April 4, 2025. (F3) This option has fully vested. |